United Therapeutics Cooke Pharma Buyout Provides Added Marketing/R&D
This article was originally published in The Tan Sheet
Executive Summary
United Therapeutics Corporation's acquisition of Cooke Pharma will give the HeartBar manufacturer a boost in marketing and research and development resources.
You may also be interested in...
FTC settles with HeartBar marketers
Unither Pharma and United Therapeutics will cease making certain ad claims for their L-arginine-containing HeartBar following FTC allegations the claims are unsupported by scientific evidence, according to 1June 12 settlement. Agreement prohibits multiple claims such as "HeartBar decreases leg pain, prevents age-related vascular problems, reduces the risk of cardiovascular disease and reduces or eliminates the need for surgery and medications among patients with" CVD, which appeared on 2Unither's Web site and in print ads, FTC says. United Therapeutics acquired HeartBar when it purchased Cooke Pharma in 2000 (3"The Tan Sheet" Jan. 1, 2001, p. 5)...
FTC settles with HeartBar marketers
Unither Pharma and United Therapeutics will cease making certain ad claims for their L-arginine-containing HeartBar following FTC allegations the claims are unsupported by scientific evidence, according to 1June 12 settlement. Agreement prohibits multiple claims such as "HeartBar decreases leg pain, prevents age-related vascular problems, reduces the risk of cardiovascular disease and reduces or eliminates the need for surgery and medications among patients with" CVD, which appeared on 2Unither's Web site and in print ads, FTC says. United Therapeutics acquired HeartBar when it purchased Cooke Pharma in 2000 (3"The Tan Sheet" Jan. 1, 2001, p. 5)...
FTC settles with HeartBar marketers
Unither Pharma and United Therapeutics will cease making certain ad claims for their L-arginine-containing HeartBar following FTC allegations the claims are unsupported by scientific evidence, according to 1June 12 settlement. Agreement prohibits multiple claims such as "HeartBar decreases leg pain, prevents age-related vascular problems, reduces the risk of cardiovascular disease and reduces or eliminates the need for surgery and medications among patients with" CVD, which appeared on 2Unither's Web site and in print ads, FTC says. United Therapeutics acquired HeartBar when it purchased Cooke Pharma in 2000 (3"The Tan Sheet" Jan. 1, 2001, p. 5)...